These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24428732)

  • 1. Lost in Translation (LiT): IUPHAR Review 6.
    Dollery CT
    Br J Pharmacol; 2014 May; 171(9):2269-90. PubMed ID: 24428732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Modern Drug Discovery.
    Eder J; Herrling PL
    Handb Exp Pharmacol; 2016; 232():3-22. PubMed ID: 26330257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical translation of cell-based pharmacogenomic discovery.
    Cox NJ; Gamazon ER; Wheeler HE; Dolan ME
    Clin Pharmacol Ther; 2012 Oct; 92(4):425-7. PubMed ID: 22910437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery in advanced prostate cancer: translating biology into therapy.
    Yap TA; Smith AD; Ferraldeschi R; Al-Lazikani B; Workman P; de Bono JS
    Nat Rev Drug Discov; 2016 Oct; 15(10):699-718. PubMed ID: 27444228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T4 Translational Moonshot: Making Cardiovascular Discoveries Work for Everyone.
    Westfall JM; Mensah GA
    Circ Res; 2018 Jan; 122(2):210-212. PubMed ID: 29348250
    [No Abstract]   [Full Text] [Related]  

  • 6. Data-driven medicinal chemistry in the era of big data.
    Lusher SJ; McGuire R; van Schaik RC; Nicholson CD; de Vlieg J
    Drug Discov Today; 2014 Jul; 19(7):859-68. PubMed ID: 24361338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential of translational bioinformatics approaches for pharmacology research.
    Li L
    Br J Clin Pharmacol; 2015 Oct; 80(4):862-7. PubMed ID: 25753093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational Informatics Connects Real-World Information to Knowledge in an Increasingly Data-Driven World.
    McDonough CW; Breitenstein MK; Shahin M; Empey PE; Freimuth RR; Li L; Liebman M; Tuteja S
    Clin Pharmacol Ther; 2020 Apr; 107(4):738-741. PubMed ID: 31837229
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitigating risk in academic preclinical drug discovery.
    Dahlin JL; Inglese J; Walters MA
    Nat Rev Drug Discov; 2015 Apr; 14(4):279-94. PubMed ID: 25829283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japan-China Joint Medical Workshop on Drug Discoveries and Therapeutics 2008: The need of Asian pharmaceutical researchers' cooperation.
    Nakata M; Tang W
    Drug Discov Ther; 2008 Oct; 2(5):262-3. PubMed ID: 22504718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientific diligence for oncology drugs: a pharmacology, translational medicine and clinical perspective.
    Parasrampuria DA; Bandekar R; Puchalski TA
    Drug Discov Today; 2020 Oct; 25(10):1855-1864. PubMed ID: 32693162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery in clinical and translational medicine.
    Wang DC; Wang X
    Clin Transl Med; 2021 Oct; 11(10):e568. PubMed ID: 34709762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. canSAR: update to the cancer translational research and drug discovery knowledgebase.
    Mitsopoulos C; Di Micco P; Fernandez EV; Dolciami D; Holt E; Mica IL; Coker EA; Tym JE; Campbell J; Che KH; Ozer B; Kannas C; Antolin AA; Workman P; Al-Lazikani B
    Nucleic Acids Res; 2021 Jan; 49(D1):D1074-D1082. PubMed ID: 33219674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in basic and translational tuberculosis research: Proceedings of the first meeting of RePORT international.
    Geadas C; Stoszek SK; Sherman D; Andrade BB; Srinivasan S; Hamilton CD; Ellner J
    Tuberculosis (Edinb); 2017 Jan; 102():55-67. PubMed ID: 28061953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Machine Learning in Translational Medicine: Current Status and Future Opportunities.
    Terranova N; Venkatakrishnan K; Benincosa LJ
    AAPS J; 2021 May; 23(4):74. PubMed ID: 34008139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expanding role of immunopharmacology: IUPHAR Review 16.
    Tiligada E; Ishii M; Riccardi C; Spedding M; Simon HU; Teixeira MM; Cuervo ML; Holgate ST; Levi-Schaffer F
    Br J Pharmacol; 2015 Sep; 172(17):4217-27. PubMed ID: 26173913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of the attrition of drug candidates from four major pharmaceutical companies.
    Waring MJ; Arrowsmith J; Leach AR; Leeson PD; Mandrell S; Owen RM; Pairaudeau G; Pennie WD; Pickett SD; Wang J; Wallace O; Weir A
    Nat Rev Drug Discov; 2015 Jul; 14(7):475-86. PubMed ID: 26091267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Big data: the next frontier for innovation in therapeutics and healthcare.
    Issa NT; Byers SW; Dakshanamurthy S
    Expert Rev Clin Pharmacol; 2014 May; 7(3):293-8. PubMed ID: 24702684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative metabolic physiology in the 'omics' era: a call to arms, paws, flippers, and claws.
    Adams SH; Barnes KM; Odle J
    Adv Nutr; 2013 Sep; 4(5):568-9. PubMed ID: 24038260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.